What We're Reading: Page 275
Industry reads hand-picked by our editors
Jun 07, 2018
-
Forbes
A biotech executive faces end-stage cancer as a patient
-
The New York Times
A promising cancer treatment made patients worse, not better
-
Bloomberg
Zero profit, 750% return: Biotech’s sick ride
-
Medical Marketing & Media
Is it time for pharma ad agencies to reboot?
Jun 06, 2018
Jun 05, 2018
Jun 04, 2018
Jun 01, 2018
May 31, 2018
-
Financial Times
Drugmakers struggle to find immunotherapy combinations for cancer
-
The Atlantic
Why Egypt is at the forefront of hepatitis C treatment
-
The Washington Post
This mock pandemic killed 150 million people. Next time it might not be a drill.
-
Forbes
Inside the gene factory
May 30, 2018
-
The Wall Street Journal
Are big clinical trials relevant? Researchers disagree
-
Reuters
India’s drug regulator expects to finalize new clinical trial rules in two months
-
The Atlantic
Genetic intelligence tests are next to worthless
-
Massive
'Orphan drugs' are ascendant. What will that mean for people with rare diseases?
Previous
